Wendy Kay Kellam, PAC in Vancouver, WA - Medicare Physician Assistant Provider

Wendy Kay Kellam, PAC is a medicare enrolled "Physician Assistant" provider in Vancouver, Washington. Her current practice location is 2811 Ne 139th St, Vancouver, Washington. You can reach out to her office (for appointments etc.) via phone at (360) 574-5247.

Wendy Kay Kellam is licensed to practice in Washington (license number PA60638000) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1083892665.

Contact Information

	Wendy Kay Kellam, PAC
	2811 Ne 139th St, Vancouver, WA 98686-2724
	(360) 574-5247
	Not Available

Healthcare Provider's Profile

Full Name	Wendy Kay Kellam
Gender	Female
Speciality	Physician Assistant
Location	2811 Ne 139th St, Vancouver, Washington
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1083892665
Provider Enumeration Date: 02/05/2008
Last Update Date: 10/14/2020

Medicare PECOS Information:

PECOS PAC ID: 3577793439
Enrollment ID: I20140220001764

Medical Identifiers

Medical identifiers for Wendy Kay Kellam such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083892665	NPI	-	NPPES
1083892665	Medicaid	WA
500663009	Medicaid	OR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	(* (Not Available))	Secondary
363AM0700X	Physician Assistant - Medical	PA164630 (Oregon)	Secondary
363A00000X	Physician Assistant	PA60638000 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Wendy Kay Kellam is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Wendy Kay Kellam, PAC Po Box 4825, Portland, OR 97208-4825 Ph: (360) 882-2778	Wendy Kay Kellam, PAC 2811 Ne 139th St, Vancouver, WA 98686-2724 Ph: (360) 574-5247

News Archive

Researchers highlight importance of large population studies for increased knowledge about disease

Per Magnus, director of the Norwegian Mother and Child Cohort Study at the NIPH, together with two researchers from the UK and Denmark, have written a commentary article in the latest issue of the prestigious journal JAMA Pediatrics. The journal is published by the American Medical Association.

Real-time genomics to track SARS-CoV-2 help contain transmission in New Zealand

A recent study discusses how New Zealand rapidly employed real-time genomics to contain new COVID-19 cases.

Study shows new antibody resistant variants can emerge in patients treated with monoclonal antibodies

A new study, published on the medRxiv* preprint server, suggested that selective pressures induced by the administration of monoclonal antibodies (Bamlanivimab) may require increased genomic surveillance to identify and control the spread of therapy-induced variants.

Skin infections in AD patients linked to PMN impairment

Impairment of polymorphonuclear granulocytes among patients with atopic dermatitis may represent an additional cause of skin infections, suggest study findings.

Zacharon, Pfizer enter research collaboration to develop drugs for orphan diseases

Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.

Wendy Kay Kellam, PAC - Medicare in Vancouver, WA